Celgen Biopharma
Shanghai · Founded 2000
About Celgen Biopharma
Shanghai Celgen Biopharma Co., Ltd. (上海赛金) is mainly engaged in the research and development, production, and sales of biological medicinal products of recombinant proteins and monoclonal antibodies used in the field of immune disease and cancer. As a biopharmaceutical enterprise engaged professionally in researching and developing, producing, and selling biopharmaceutical products, Celgen Biopharma has already built up a professional platform for the phages antibody screening library, a CHO cell clone development platform recognized by FDA/EMEA, and a world-class platform to culture CHO cells without serum or antibiotics, an advanced purification platform, a complete analysis platform, a technology development platform of ""quality stems from design"", a vitro drug active research platform, and a vivo activity evaluation technology platform.
Company Facts
- Founded: 2000
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Last round: Series Unknown (Jul 2009)
- Website: celgenpharm.com
- Phone: 400 921 7071
Social Profiles
Canonical: https://fsome.com/organization/celgen-biopharma-8300861 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.